FDA Drug recall D-0552-2026
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ…
- FDA Drug
- Class III
- ongoing
- Published 2026-06-10
On 2026-06-10 the FDA classified a Class III recall of Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ… by Eugia Us, citing labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0552-2026 |
| Classification | Class III |
| Status | ongoing |
| Initiated | 2026-05-18 |
| Published | 2026-06-10 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Eugia Us |
| Distribution | US |
Product
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02
Reason
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Identifiers
| ndc | 76420-760-01 |
|---|---|
| ndc | 55150-164-02 |
| ndc | 70121-1049-5 |
| ndc | 67777-419-02 |
| code_info | Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0552-2026%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.